Trials / Completed
CompletedNCT00314158
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 523 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension | One drop twice daily in each study eye for six months |
| DRUG | Brinzolamide 10 mg/ml (AZOPT) eye drops, suspension | One drop twice daily in each study eye for six months |
| DRUG | Timolol 5 mg/ml eye drops, solution | One drop twice daily in each study eye for six months |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2007-01-01
- Completion
- 2007-01-01
- First posted
- 2006-04-13
- Last updated
- 2016-11-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00314158. Inclusion in this directory is not an endorsement.